共 7 条
[1]
[2]
Carvedilol Protects Better Against Vascular Events Than Metoprolol in Heart Failure[J] Willem J. Remme;Christian Torp-Pedersen;John G.F. Cleland;Philip A. Poole-Wilson;Marco Metra;Michel Komajda;Karl Swedberg;Andrea Di Lenarda;Phillip Spark;Armin Scherhag;Christine Moullet;Mary Ann Lukas Journal of the American College of Cardiology 2007,
[3]
Effects of carvedilol early after myocardial infarction: Analysis of the first 30 days in Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN)[J] Gregg C. Fonarow;Mary Ann Lukas;Michele Robertson;Wilson S. Colucci;Henry J. Dargie American Heart Journal 2007,
[4]
Altered fibroblast function following myocardial infarction[J] Christina E. Squires;G. Patricia Escobar;John F. Payne;Robert A. Leonardi;Danielle K. Goshorn;Nina J. Sheats;I. Matthew Mains;Joseph T. Mingoia;English C. Flack;Merry L. Lindsey Journal of Molecular and Cellular Cardiology 2005,
[5]
Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial[J] Dargie H J The Lancet 2001,
[6]
Left and right ventricular collagen type I/III ratios and remodeling post-myocardial infarction[J] Shan Wei;Louis T.C. Chow;Irene O.L. Shum;Ling Qin;John E. Sanderson Journal of Cardiac Failure 1999,
[7]
Experimental Autoimmune Myocarditis Produced by Adoptive Transfer of Splenocytes After Myocardial Infarction[J] Alan Maisel;David Cesario;Stephen Baird;Jalees Rehman;Parviz Haghighi;Steve Carter Circulation Research 1998,

